Solid Biosciences Inc.
SLDB
$9.54
-$0.39-3.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 44.75M | 40.91M | 38.88M | 36.74M | 35.40M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 212.15M | 196.46M | 179.21M | 169.70M | 156.82M |
| Operating Income | -212.15M | -196.46M | -179.21M | -169.70M | -156.82M |
| Income Before Tax | -207.10M | -191.78M | -174.33M | -167.14M | -154.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -207.10 | -191.78 | -174.33 | -167.14 | -154.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -207.10M | -191.78M | -174.33M | -167.14M | -154.08M |
| EBIT | -212.15M | -196.46M | -179.21M | -169.70M | -156.82M |
| EBITDA | -210.52M | -194.84M | -177.57M | -168.04M | -155.14M |
| EPS Basic | -1.91 | -1.95 | -2.02 | -2.49 | -2.80 |
| Normalized Basic EPS | -1.19 | -1.22 | -1.26 | -1.56 | -1.75 |
| EPS Diluted | -1.91 | -1.95 | -2.02 | -2.49 | -2.80 |
| Normalized Diluted EPS | -1.19 | -1.22 | -1.26 | -1.56 | -1.75 |
| Average Basic Shares Outstanding | 442.65M | 393.10M | 349.63M | 297.61M | 244.63M |
| Average Diluted Shares Outstanding | 442.65M | 393.10M | 349.63M | 297.61M | 244.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |